Teva Pharmaceutical Industries Ltd. has announced that the U.S. Food and Drug Administration has granted approval for the company's generic Alprazolam Extended Release 0.5 mg, 1 mg, 2 mg and 3 mg tablets. Shipment of this product will begin immediately.
Teva's product is the AB-rated equivalent of Pharmacia and Upjohn's Xanax® XR Tablets, a product indicated for treatment of panic disorder.